| 10384234
|
Picornaviruses: epitopes, canyons, and pockets. |
Adv Virus Res |
1999 |
Smith TJ;Baker T |
View
More |
| 10822251
|
Influence of three-dimensional structure on the immunogenicity of a peptide expressed on the surface of a plant virus. |
J Mol Recognit |
2000 |
Taylor KM;Lin T;Porta C;Mosser AG;Giesing HA;Lomonossoff GP;Johnson JE |
View
More |
| 11509871
|
HBV core particles as a carrier for B cell/T cell epitopes. |
Intervirology |
2001 |
Pumpens P;Grens E |
View
More |
| 1370851
|
Isolation and characterization of two distinct human rotavirus strains with G6 specificity. |
J Clin Microbiol |
1992 |
Gerna G;Sarasini A;Parea M;Arista S;Miranda P;Brussow H;Hoshino Y;Flores J |
View
More |
| 1373343
|
Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-A. |
Cancer Immunol Immunother |
1992 |
Hayashi Y;Hoon DS;Park MS;Terasaki PI;Morton DL |
View
More |
| 15755565
|
On the need for, and the delivery of, cross-protective vaccines. |
Vaccine |
2005 |
Spier RE |
View
More |
| 16221070
|
Development of cowpea mosaic virus-based vectors for the production of vaccines in plants. |
Expert Rev Vaccines |
2005 |
Canizares MC;Lomonossoff GP;Nicholson L |
View
More |
| 1693163
|
Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria. |
J Gen Virol |
1990 |
Clarke BE;Brown AL;Grace KG;Hastings GZ;Brown F;Rowlands DJ;Francis MJ |
View
More |
| 1693662
|
Neutralization epitopes of human rhinovirus type 2. |
J Gen Virol |
1990 |
Appleyard G;Russell SM;Clarke BE;Speller SA;Trowbridge M;Vadolas J |
View
More |
| 16978788
|
Tandem copies of a human rotavirus VP8 epitope can induce specific neutralizing antibodies in BALB/c mice. |
Biochim Biophys Acta |
2006 |
Kovacs-Nolan J;Mine Y |
View
More |
| 1699132
|
Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. |
Nature |
1990 |
Parry N;Fox G;Rowlands D;Brown F;Fry E;Acharya R;Logan D;Stuart D |
View
More |
| 1701477
|
Identification of operationally overlapping and independent cross-reactive neutralization regions on human rotavirus VP4. |
J Gen Virol |
1990 |
Kobayashi N;Taniguchi K;Urasawa S |
View
More |
| 1703215
|
Neutralizing antibodies to human rhinovirus produced in laboratory animals and humans that recognize a linear sequence from VP2. |
J Gen Virol |
1990 |
Hastings GZ;Speller SA;Francis MJ |
View
More |
| 1704653
|
Characterization of Mengo virus neutralization epitopes. |
Virology |
1991 |
Boege U;Kobasa D;Onodera S;Parks GD;Palmenberg AC;Scraba DG |
View
More |
| 1715847
|
Generation of recombinant, carbohydrate-free intercellular adhesion molecule-1 (ICAM-1) and ICAM-1 fragments in Escherichia coli and mapping of epitopes recognized by anti-ICAM-1 monoclonal antibodies. |
Immunol Lett |
1991 |
Molgg M;Schwaeble W;Johnson JP;Dierich MP |
View
More |
| 1716769
|
Identification of monoclonal antibody epitopes and critical residues for rhinovirus binding in domain 1 of intercellular adhesion molecule 1. |
Proc Natl Acad Sci U S A |
1991 |
McClelland A;deBear J;Yost SC;Meyer AM;Marlor CW;Greve JM |
View
More |
| 1719231
|
Human-murine chimeras of ICAM-1 identify amino acid residues critical for rhinovirus and antibody binding. |
J Virol |
1991 |
Register RB;Uncapher CR;Naylor AM;Lineberger DW;Colonno RJ |
View
More |
| 1722090
|
Preparation and characterization of a neutralizing monoclonal antibody directed to VP4 of rotavirus strain K8 which has unique VP4 neutralization epitopes. |
Arch Virol |
1991 |
Kobayashi N;Taniguchi K;Urasawa T;Urasawa S |
View
More |
| 1722503
|
Proliferative responses of T cells primed against human rhinovirus to other rhinovirus serotypes. |
J Gen Virol |
1991 |
Hastings GZ;Rowlands DJ;Francis MJ |
View
More |
| 1722937
|
Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted. |
Vaccine |
1991 |
Brown AL;Francis MJ;Hastings GZ;Parry NR;Barnett PV;Rowlands DJ;Clarke BE |
View
More |
| 19026659
|
In silico vaccine design based on molecular simulations of rhinovirus chimeras presenting HIV-1 gp41 epitopes. |
J Mol Biol |
2009 |
Lapelosa M;Gallicchio E;Arnold GF;Arnold E;Levy RM |
View
More |
| 19279101
|
Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitope. |
J Virol |
2009 |
Arnold GF;Velasco PK;Holmes AK;Wrin T;Geisler SC;Phung P;Tian Y;Resnick DA;Ma X;Mariano TM;Petropoulos CJ;Taylor JW;Katinger H;Arnold E |
View
More |
| 20138057
|
Antigenic characteristics of rhinovirus chimeras designed in silico for enhanced presentation of HIV-1 gp41 epitopes [corrected]. |
J Mol Biol |
2010 |
Lapelosa M;Arnold GF;Gallicchio E;Arnold E;Levy RM |
View
More |
| 2170568
|
The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host\'s previous exposure to similar epitopes on unrelated antigens. |
J Gen Virol |
1990 |
Davis D;Chaudhri B;Stephens DM;Carne CA;Willers C;Lachmann PJ |
View
More |
| 22121050
|
Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections. |
FASEB J |
2012 |
Niespodziana K;Napora K;Cabauatan C;Focke-Tejkl M;Keller W;Niederberger V;Tsolia M;Christodoulou I;Papadopoulos NG;Valenta R |
View
More |
| 22560151
|
High titers of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirus. |
J Allergy Clin Immunol |
2012 |
Soto-Quiros M;Avila L;Platts-Mills TA;Hunt JF;Erdman DD;Carper H;Murphy DD;Odio S;James HR;Patrie JT;Hunt W;O'Rourke AK;Davis MD;Steinke JW;Lu X;Kennedy J;Heymann PW |
View
More |
| 22657145
|
Functionalizing gold nanoparticles with bluetongue virus multiple peptide antigens utilizing gold-thiol interaction: a novel approach to develop pen side test. |
Res Vet Sci |
2012 |
Saxena VK;Deb R;Shrivastava S;Kantaraja C;Kumar A;Kumar S |
View
More |
| 24039745
|
Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses. |
PLoS One |
2013 |
Yi G;Lapelosa M;Bradley R;Mariano TM;Dietz DE;Hughes S;Wrin T;Petropoulos C;Gallicchio E;Levy RM;Arnold E;Arnold GF |
View
More |
| 2413124
|
Cross-reactive recognition of mouse cells expressing the bm3 and bm11 mutations within H-2Kb by H-2Kb-restricted herpes simplex virus-specific cytotoxic T lymphocytes. |
J Immunol |
1985 |
Jennings SR |
View
More |
| 2416951
|
Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. |
J Virol |
1986 |
Sherry B;Mosser AG;Colonno RJ;Rueckert RR |
View
More |
| 2434607
|
A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2. |
J Gen Virol |
1987 |
Skern T;Neubauer C;Frasel L;Grundler P;Sommergruber W;Zorn M;Kuechler E;Blaas D |
View
More |
| 2437322
|
Cross-reactive neutralization epitopes on VP3 of human rotavirus: analysis with monoclonal antibodies and antigenic variants. |
J Virol |
1987 |
Taniguchi K;Morita Y;Urasawa T;Urasawa S |
View
More |
| 2444889
|
Different rhinovirus serotypes neutralized by antipeptide antibodies. |
Nature |
1987 |
McCray J;Werner G |
View
More |
| 2448418
|
Analysis of serotype-specific neutralization epitopes on VP7 of human rotavirus by the use of neutralizing monoclonal antibodies and antigenic variants. |
J Gen Virol |
1988 |
Morita Y;Taniguchi K;Urasawa T;Urasawa S |
View
More |
| 2455819
|
Antigenic sites on foot-and-mouth disease virus type A10. |
J Virol |
1988 |
Thomas AA;Woortmeijer RJ;Puijk W;Barteling SJ |
View
More |
| 2460866
|
Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. |
Proc Natl Acad Sci U S A |
1988 |
Ping LH;Jansen RW;Stapleton JT;Cohen JI;Lemon SM |
View
More |
| 2471354
|
N-AgIB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152. |
Virology |
1989 |
Wiegers K;Uhlig H;Dernick R |
View
More |
| 2482756
|
Prediction of secondary structure, spatial organization and distribution of antigenic determinants for hepatitis A virus proteins. |
J Biomol Struct Dyn |
1987 |
Mesyanzhinov VV;Peletskaya EN;Zhdanov VM;Efimov AV;Finkelstein AV;Ivanovsky DI |
View
More |
| 25261314
|
Reverse genetic engineering of the human rhinovirus serotype 16 genome to introduce an antibody-detectable tag. |
Methods Mol Biol |
2015 |
Walker EJ;Jensen LM;Ghildyal R |
View
More |
| 26061648
|
Human Rhinovirus Presenting 4E10 Epitope of HIV-1 MPER Elicits Neutralizing Antibodies in Human ICAM-1 Transgenic Mice. |
Mol Ther |
2015 |
Yi G;Tu X;Bharaj P;Guo H;Zhang J;Shankar P;Manjunath N |
View
More |
| 27591323
|
Circulating Memory CD4+ T Cells Target Conserved Epitopes of Rhinovirus Capsid Proteins and Respond Rapidly to Experimental Infection in Humans. |
J Immunol |
2016 |
Muehling LM;Mai DT;Kwok WW;Heymann PW;Pomes A;Woodfolk JA |
View
More |
| 27630239
|
Immunodominant T-Cell Epitopes in the VP1 Capsid Protein of Rhinovirus Species A and C. |
J Virol |
2016 |
Gaido CM;Stone S;Chopra A;Thomas WR;Le Souef PN;Hales BJ |
View
More |
| 31003914
|
Epitope mapping of antibodies induced with a conserved rhinovirus protein generating protective anti-rhinovirus immunity. |
Vaccine |
2019 |
Sam Narean J;Glanville N;Nunn CM;Niespodziana K;Valenta R;Johnston SL;McLean GR |
View
More |
| 31075351
|
Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease. |
Antiviral Res |
2019 |
Kotomina T;Isakova-Sivak I;Matyushenko V;Kim KH;Lee Y;Jung YJ;Kang SM;Rudenko L |
View
More |
| 31416365
|
Overview of human rhinovirus immunogenic epitopes for rational vaccine design. |
Expert Rev Vaccines |
2019 |
Stepanova E;Isakova-Sivak I;Rudenko L |
View
More |
| 31464554
|
Vaccine strategies to induce broadly protective immunity to rhinoviruses. |
Hum Vaccin Immunother |
2020 |
McLean GR |
View
More |
| 31490930
|
A general approach for predicting protein epitopes targeted by antibody repertoires using whole proteomes. |
PLoS One |
2019 |
Paull ML;Johnston T;Ibsen KN;Bozekowski JD;Daugherty PS |
View
More |
| 32467165
|
Inhibitory antibodies identify unique sites of therapeutic vulnerability in rhinovirus and other enteroviruses. |
Proc Natl Acad Sci U S A |
2020 |
Meng B;Lan K;Xie J;Lerner RA;Wilson IA;Yang B |
View
More |
| 32753554
|
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. |
Science |
2020 |
Mateus J;Grifoni A;Tarke A;Sidney J;Ramirez SI;Dan JM;Burger ZC;Rawlings SA;Smith DM;Phillips E;Mallal S;Lammers M;Rubiro P;Quiambao L;Sutherland A;Yu ED;da Silva Antunes R;Greenbaum J;Frazier A;Markmann AJ;Premkumar L;de Silva A;Peters B;Crotty S;Sette A;Weiskopf D |
View
More |
| 33128877
|
Unbiased Screens Show CD8(+) T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein. |
Immunity |
2020 |
Ferretti AP;Kula T;Wang Y;Nguyen DMV;Weinheimer A;Dunlap GS;Xu Q;Nabilsi N;Perullo CR;Cristofaro AW;Whitton HJ;Virbasius A;Olivier KJ Jr;Buckner LR;Alistar AT;Whitman ED;Bertino SA;Chattopadhyay S;MacBeath G |
View
More |
| 33178220
|
Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines. |
Front Immunol |
2020 |
Reche PA |
View
More |
| 33230881
|
Human rhinovirus-specific CD8 T cell responses target conserved and unusual epitopes. |
FASEB J |
2021 |
Gomez-Perosanz M;Sanchez-Trincado JL;Fernandez-Arquero M;Sidney J;Sette A;Lafuente EM;Reche PA |
View
More |
| 33239605
|
Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the \'Common Cold\'. |
Med Sci Monit |
2020 |
Stefano GB;Kream RM |
View
More |
| 33767706
|
The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic. |
Front Immunol |
2021 |
Shah P;Canziani GA;Carter EP;Chaiken I |
View
More |
| 33911008
|
Genome-Wide B Cell, CD4(+), and CD8(+) T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines. |
J Immunol |
2021 |
Prakash S;Srivastava R;Coulon PG;Dhanushkodi NR;Chentoufi AA;Tifrea DF;Edwards RA;Figueroa CJ;Schubl SD;Hsieh L;Buchmeier MJ;Bouziane M;Nesburn AB;Kuppermann BD;BenMohamed L |
View
More |
| 34026045
|
Most Japanese individuals are genetically predisposed to recognize an immunogenic protein fragment shared between COVID-19 and common cold coronaviruses. |
F1000Res |
2021 |
Dijkstra JM;Frenette AP;Dixon B |
View
More |
| 34127926
|
Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity. |
Front Immunol |
2021 |
Lehmann AA;Kirchenbaum GA;Zhang T;Reche PA;Lehmann PV |
View
More |
| 34509646
|
Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses. |
Infect Genet Evol |
2021 |
Tan CCS;Owen CJ;Tham CYL;Bertoletti A;van Dorp L;Balloux F |
View
More |
| 34571943
|
Characterization of Conserved and Promiscuous Human Rhinovirus CD4 T Cell Epitopes. |
Cells |
2021 |
Gomez-Perosanz M;Fiyouzi T;Fernandez-Arquero M;Sidney J;Sette A;Reinherz EL;Lafuente EM;Reche PA |
View
More |
| 34919800
|
HLA-A( *)02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses. |
Cell Rep |
2021 |
Nesterenko PA;McLaughlin J;Tsai BL;Burton Sojo G;Cheng D;Zhao D;Mao Z;Bangayan NJ;Obusan MB;Su Y;Ng RH;Chour W;Xie J;Li YR;Lee D;Noguchi M;Carmona C;Phillips JW;Kim JT;Yang L;Heath JR;Boutros PC;Witte ON |
View
More |
| 35328398
|
Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins. |
Int J Mol Sci |
2022 |
Tajuelo A;Lopez-Siles M;Mas V;Perez-Romero P;Aguado JM;Briz V;McConnell MJ;Martin-Galiano AJ;Lopez D |
View
More |
| 35563505
|
Identification of Epitopes on Rhinovirus 89 Capsid Proteins Capable of Inducing Neutralizing Antibodies. |
Int J Mol Sci |
2022 |
Niespodziana K;Cabauatan CR;Pazderova P;Vacal PC;Wortmann J;Keller W;Errhalt P;Valenta R |
View
More |
| 35614127
|
Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes. |
Nat Commun |
2022 |
Wang C;Hesketh EL;Shamorkina TM;Li W;Franken PJ;Drabek D;van Haperen R;Townend S;van Kuppeveld FJM;Grosveld F;Ranson NA;Snijder J;de Groot RJ;Hurdiss DL;Bosch BJ |
View
More |
| 37270034
|
Molecular evolutionary analyses of the fusion protein gene in human respirovirus 1. |
Virus Res |
2023 |
Takahashi T;Akagawa M;Kimura R;Sada M;Shirai T;Okayama K;Hayashi Y;Kondo M;Takeda M;Ryo A;Kimura H |
View
More |
| 37675108
|
Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus. |
Front Immunol |
2023 |
Bodas-Pinedo A;Lafuente EM;Pelaez-Prestel HF;Ras-Carmona A;Subiza JL;Reche PA |
View
More |
| 37684288
|
Cross-reactive MHC class I T cell epitopes may dictate heterologous immune responses between respiratory viruses and food allergens. |
Sci Rep |
2023 |
Balz K;Kaushik A;Cemic F;Sampath V;Heger V;Renz H;Nadeau K;Skevaki C |
View
More |
| 38011546
|
Low-sugar universal mRNA vaccine against coronavirus variants with deletion of glycosites in the S2 or stem of SARS-CoV-2 spike messenger RNA (mRNA). |
Proc Natl Acad Sci U S A |
2023 |
Cheng CW;Wu CY;Wang SW;Chen JY;Kung CC;Liao KS;Wong CH |
View
More |
| 4126194
|
Lack of close relationship between three strains of human rhinoviruses as determined by their RNA sequences. |
J Virol |
1973 |
Yin FH;Lonberg-Holm K;Chan SP |
View
More |
| 4126195
|
Antigenic determinants of infective and inactivated human rhinovirus type 2. |
J Virol |
1973 |
Lonberg-Holm K;Yin FH |
View
More |
| 4140469
|
Early interaction between animal viruses and cells. |
Monogr Virol |
1974 |
Lonberg-Holm K;Philipson L |
View
More |
| 47360
|
Broad antigenic relationships among rhinovirus serotypes revealed by cross-immunization of rabbits with different serotypes. |
J Immunol |
1975 |
Cooney MK;Wise JA;Kenny GE;Fox JP |
View
More |
| 61746
|
Replication of rhinoviruses. |
Arch Virol |
1976 |
Butterworth BE;Grunert RR;Korant BD;Lonberg-Holm K;Yin FH |
View
More |
| 6196431
|
Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants. |
J Exp Med |
1983 |
Gaston JS;Rickinson AB;Epstein MA |
View
More |
| 6202783
|
Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants. |
J Immunol |
1984 |
Stukart MJ;Boes J;Melief CJ |
View
More |
| 67105
|
Physicochemical characterization of two serologically unrelated equine rhinoviruses. |
Intervirology |
1977 |
Newman JF;Rowlands DJ;Brown F;Goodridge D;Burrows R;Steck F |
View
More |
| 7506839
|
Analysis of gene selection in reassortant formation between canine rotavirus K9 and human rotaviruses with different antigenic specificities. |
Res Virol |
1993 |
Kobayashi N;Taniguchi K;Urasawa T;Urasawa S |
View
More |
| 7507283
|
Design and construction of rhinovirus chimeras incorporating immunogens from polio, influenza, and human immunodeficiency viruses. |
Virology |
1994 |
Arnold GF;Resnick DA;Li Y;Zhang A;Smith AD;Geisler SC;Jacobo-Molina A;Lee W;Webster RG;Arnold E |
View
More |
| 7512613
|
Rapid culture-amplified immunofluorescent test for the detection of human rhinoviruses in clinical samples: evidence of a common epitope in culture. |
J Med Virol |
1994 |
al-Mulla W;el Mekki A;al-Nakib W |
View
More |
| 7530390
|
Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3. |
Virology |
1995 |
Padilla-Noriega L;Dunn SJ;Lopez S;Greenberg HB;Arias CF |
View
More |
| 7679742
|
Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody. |
J Virol |
1993 |
Smith TJ;Olson NH;Cheng RH;Liu H;Chase ES;Lee WM;Leippe DM;Mosser AG;Rueckert RR;Baker TS |
View
More |
| 7679749
|
Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus. |
J Virol |
1993 |
Graham S;Wang EC;Jenkins O;Borysiewicz LK |
View
More |
| 7681440
|
Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies. |
J Clin Microbiol |
1993 |
Padilla-Noriega L;Werner-Eckert R;Mackow ER;Gorziglia M;Larralde G;Taniguchi K;Greenberg HB |
View
More |
| 7690329
|
Epitope analysis of the T cell response to a complex antigen: proliferative responses to human rhinovirus capsids. |
Eur J Immunol |
1993 |
Hastings GZ;Francis MJ;Rowlands DJ;Chain BM |
View
More |
| 8848050
|
Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon. |
Nature |
1996 |
Smith TJ;Chase ES;Schmidt TJ;Olson NH;Baker TS |
View
More |
| 8906858
|
Preferential recognition of the very low-density lipoprotein receptor ligand binding site by antibodies from phage display libraries. |
FEBS Lett |
1996 |
Pfistermueller DM;Blaas D;Hodits RA |
View
More |
| 8957672
|
Chimeric rhinoviruses as tools for vaccine development and characterization of protein epitopes. |
Intervirology |
1996 |
Arnold GF;Resnick DA;Smith AD;Geisler SC;Holmes AK;Arnold E |
View
More |
| 9211643
|
Recent structural solutions for antibody neutralization of viruses. |
Trends Microbiol |
1997 |
Stewart PL;Nemerow GR |
View
More |
| 9570544
|
Eosinophils bind rhinovirus and activate virus-specific T cells. |
J Immunol |
1998 |
Handzel ZT;Busse WW;Sedgwick JB;Vrtis R;Lee WM;Kelly EA;Gern JE |
View
More |
| 9880807
|
Recombinant human monoclonal Fab fragments against rotavirus from phage display combinatorial libraries. |
J Biochem |
1999 |
Itoh K;Nakagomi O;Suzuki K;Inoue K;Tada H;Suzuki T |
View
More |
